The Online Resource for
the Hematopoiesis Research Community
#htmlcaption1
 
 

TWITTER FEED

SUBSCRIBE

Sign up today to save time and keep current by receiving free, weekly science newsletters delivered directly to your inbox!
  • “I really enjoy your weekly provided update, it saves time, reflects the hematopoiesis / hematology field (nice!!: basic research AND clinical/translational trials)! Thanks so much!”

    – Nina Schweinfurth, MD, PhD
    Central Institue of Mental Health Mannheim, Germany

  • “I really enjoy your newsletters and look forward to receiving them.”

    – Kathryn Futrega, B.Sc
    PhD Student
    Queensland University of Technology

  • “I often look forward to the weekly summaries from Connexon.”

    – Kristopher Lofgren, PhD
    Boston Children’s Hospital

  • “Great newsletter, especially like the weekly summary of articles in my field in my inbox so I don’t have to go looking for them.”

    – Jennifer Adair, PhD, Fred Hutchinson Cancer Research Center and University of Washington

  • “I inadvertently got signed up for the newsletter. But because I found it so useful and informative, I have remained subscribed and actually recommended it to others.”

    – Gregory Weber, PhD
    Rutgers, The State University of New Jersey

  • “Thank you so much for your email and your great newsletters. My team and I really enjoy them, and I cover your “MSC news” in our group meeting each Monday.”

    – Jan Nolta, PhD
    Professor, UC Davis School of Medicine

  • “I have found these newsletters to be very valuable resources.”

    – Dean Yamaguchi, MD, PhD
    Associate Chief of Staff
    VA Greater Los Angeles Healthcare System

 

About Hematopoiesis News

History:

Highlighting the most recent hematopoietic stem cell research and news updates since 2010, Hematopoiesis News provides researchers and medical professionals around the globe with a weekly resource that is reliable, convenient and current. By publishing weekly newsletters prepared by our expert editorial team, we make sure that our audience stays up-to-date with the top research articles, reviews and press releases in the field of hematopoiesis, bone marrow disorders and leukemia. Our goal is to serve the hematopoiesis research community by facilitating the communication of cutting edge science.

Scope:

Hematopoiesis News offers readers the convenience of accessing recently published hematopoietic stem cell research articles and reviews, along with the most current industry and academia press releases in one place. The Laboratory Research section of the newsletter features high-impact research articles discussing the regulation, expression patterns, differentiation and characterization of both aberrant and healthy hematopoietic stem cells at the cell culture and model organism levels. The Clinical Research section of the newsletter focuses on the therapeutic use of hematopoietic stem cells to treat blood and bone marrow disorders such as aplastic anemia, myelodysplastic syndrome, myeloproliferative disorders and leukemia at the patient level. We also ensure that our readers are up-to-date with the latest industry and science news, including new and upcoming clinical trials as well as award and grant announcements, job openings and upcoming conferences in the field.

Audience:

Catering to a diverse international audience, our readership is composed of laboratory and clinical researchers, medical practitioners, academic instructors, students and biotech and pharma industry professionals interested in the hematopoietic stem cell research field. With over 4500 newsletter subscribers and a growing social media audience, we provide researchers with relevant science news in their field through our website, weekly newsletter, and daily Twitter updates. Follow us at @Hema_News! We also give researchers the opportunity to increase exposure to their work by submitting research articles, reviews, press releases, events and jobs related to hematopoietic stem cells, leukemia and other bone marrow disorders for possible inclusion in Hematopoiesis News at no cost.

STEMvision(TM) Instrument
 
RELATED PUBLICATIONS